ArthroCare Sports Medicine Launches Mobile Surgical Skills Center

ArthroCare® Corp. (Nasdaq: ARTC) announced today the launch of its new Mobile Surgical Skills Center – a fully operational, five station skills center for sports medicine related surgical training and physician education purposes. The ArthroCare Mobile Surgical Skills Center is equipped with five complete training stations. Each station contains full visualization equipment for arthroscopic and other procedures and room for two surgeons plus one assistant, if needed. The Mobile Surgical Skills Center provides surgeons around the country with the opportunity to learn techniques and utilize ArthroCare’s various Sports Medicine technologies first-hand. From ArthroCare’s various Coblation® devices such as the Topaz® MicroDebrider to their Opus® technologies for arthroscopic shoulder repair and their array of Atlantech® instruments, the complete spectrum of the company’s sports medicine equipment will be available in the lab. "We’re very excited about the launch of our first ever mobile training center,” said Jack Giroux, president of ArthroCare Sports Medicine. "We’ve worked to make sure that it is decked out with everything you would get from a regular state-of-the-art training facility, but in a format that allows us to take it on the road and reach surgeons in all parts of the country.” Giroux added that the ArthroCare Mobile Surgical Skills Center will be making stops at most of the major sports medicine and orthopedic shows as well as at teaching hospitals and medical centers around the country. The mobile training center will be making several stops in the Southeast region of the country in the next couple of months and will continue to make its way around the country throughout the year. Note to Media: Photos of the ArthroCare Mobile Surgical Skills Center are available by contacting Paul Williams at 949/916-6880 or via medialine2@aol.com. About ArthroCare Founded in 1993, ArthroCare Corp. (www.arthrocare.com) is a highly innovative, multi-business medical device company that develops, manufactures and markets minimally invasive surgical products. With these products, ArthroCare targets a multi-billion Dollar market opportunity across several medical specialties, significantly improving existing surgical procedures and enabling new, minimally invasive procedures. Many of ArthroCare’s products are based on its patented Coblation technology, which uses low-temperature radiofrequency energy to gently and precisely dissolve rather than burn soft tissue –– minimizing damage to healthy tissue. Used in more than four million surgeries worldwide, Coblation-based devices have been developed and marketed for sports medicine; spine/neurologic; ear, nose and throat (ENT); cosmetic; urologic and gynecologic procedures. ArthroCare also has added a number of novel technologies to its portfolio, including Opus Medical sports medicine, Parallax spine and Applied Therapeutics ENT products, to complement Coblation within key indications. SAFE HARBOR STATEMENTS Except for historical information, this press release includes forward-looking statements. These statements include, but are not limited to, the company's stated business outlook for fiscal 2008, continued strength of the company's fundamental position, the strength of the company's technology, the company's belief that strategic moves will enhance achievement of the company's long term potential, the potential and expected rate of growth of new businesses, continued success of product diversification efforts, and other statements that involve risks and uncertainties. These risks and uncertainties include, but are not limited to the uncertainty of success of the company's non-arthroscopic products, competitive risk, uncertainty of the success of strategic business alliances, uncertainty over reimbursement, need for governmental clearances or approvals before selling products, the uncertainty of protecting the company's patent position, and any changes in financial results from completion of year-end audit activities. These and other risks and uncertainties are detailed from time to time in the company's Securities and Exchange Commission filings, including ArthroCare’s Form 10-K for the year ended Dec. 31, 2007. Forward-looking statements are indicated by words or phrases such as "anticipates," "estimates," "projects," "believes," "intends," "expects," and similar words and phrases. Actual results may differ materially from management expectations.